Evidence map›Paper›PMID 42856583›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Predicting PANSS symptoms in schizophrenia spectrum disorders using speech only: an international, multi-centre, computational secondary analysis across multiple languages.

Rui He, Maryia Kirdun, Claudio Palominos, Lara Navarrete Orejudo, Sophie Barthelemy, Simran Bhola, Silvia Ciampelli, Amandine Decker, Cemal Demirlek, Riccardo Fusaroli and 27 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors.

Rui HeGrammar and Cognition Lab, Department of Translation & Language Sciences, Universitat Pompeu Fabra, Barcelona, Spain.ORCID 0000-0001-6999-1920
Maryia KirdunGrammar and Cognition Lab, Department of Translation & Language Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Claudio PalominosGrammar and Cognition Lab, Department of Translation & Language Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Lara Navarrete OrejudoGrammar and Cognition Lab, Department of Translation & Language Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Sophie BarthelemyAix-Marseille Université, Laboratoire de Psychologie Clinique, de Psychopathologie et de Psychanalyse (LPCPP, UR 3278), Aix-en-Provence, France.
Simran BholaZucker Hillside Hospital, Northwell Health, New York, United States of America.
Silvia CiampelliCenter for Clinical Neuroscience and Cognition and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Amandine DeckerUniversité de Lorraine, Nancy, France.
Cemal DemirlekDepartment of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, Massachusetts, United States of America.ORCID 0000-0001-6195-6899
Riccardo FusaroliDepartment of Linguistics, Cognitive Science and Semiotics, Aarhus University, Aarhus, Denmark.
José Tomás García-MolinaDepartment of Psychiatry and Mental Health, South Campus, School of Medicine, University of Chile, Santiago, Chile.
Guy GimenezAix-Marseille Université, Laboratoire de Psychologie Clinique, de Psychopathologie et de Psychanalyse (LPCPP, UR 3278), Aix-en-Provence, France.
Roya HüppiDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.
Katja KoelkebeckBielefeld University, Medical School and University Medical Center OWL, Protestant Hospital of the Bethel Foundation, Department of Psychiatry and Psychotherapy, Bielefeld, Germany.
Amandine LecomteUniversité de Lorraine, Nancy, France.
Renxiang QiuMethods and Development Group "Brain Networks", Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany.ORCID 0009-0008-0659-4205
Arndis SimonsenThe Interacting Minds Center, Institute of Culture and Society, Aarhus University, Aarhus, Denmark.
Vincent TourneurUniversité de Lorraine, Nancy, France.
Burcu VerimDepartment of Neurosciences, Health Sciences Institute, Dokuz Eylul University, Izmir, Turkey.
Huiling WangDepartment of Psychiatry, Renmin Hospital of Wuhan University, Wuhan, China.
Berna YalincetinDepartment of Neurosciences, Health Sciences Institute, Dokuz Eylul University, Izmir, Turkey.
Sandy YinZucker Hillside Hospital, Northwell Health, New York, United States of America.
Yuan ZhouDepartment of Psychology, University of Chinese Academy of Sciences, Beijing, China.
Maxime AmblardUniversité de Lorraine, Nancy, France.
Rosa Ayesa ArriolaValdecilla Research Institute (IDIVAL), Santander, Spain.
Emre BoraDepartment of Neurosciences, Health Sciences Institute, Dokuz Eylul University, Izmir, Turkey.
Janna de BoerCenter for Clinical Neuroscience and Cognition and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Alicia I Figueroa-BarraDepartment of Psychiatry and Mental Health, South Campus, School of Medicine, University of Chile, Santiago, Chile.
Sanne KoopsCenter for Clinical Neuroscience and Cognition and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Michel MusiolUniversité de Lorraine, Nancy, France.
Lena PalaniyappanDouglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
Alberto ParolaCentre for Language Technology, Department of Nordic Studies and Linguistics, Copenhagen University, Denmark.
Filip SpanielNational Institute of Mental Health, Klecany, Czech Republic.
Sunny X TangZucker Hillside Hospital, Northwell Health, New York, United States of America.
Iris E SommerCenter for Clinical Neuroscience and Cognition and Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Philipp HomanDepartment of Adult Psychiatry and Psychotherapy, University of Zurich, Zurich, Switzerland.ORCID 0000-0001-9034-148X
Wolfram HinzenGrammar and Cognition Lab, Department of Translation & Language Sciences, Universitat Pompeu Fabra, Barcelona, Spain.

Funding

Advancing Computational Linguistic Biomarkers of Disorganized Speech in PsychosisK23MH130750 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI TANG, SUNNY XIAOJING · 2022 to 2024
$586k
NIMH NIH HHS K23 MH130750Wellcome Trust
6 · The paper itself

Abstract

Background: Speech carries cues to variation in mental state in schizophrenia, typically indexed with clinician-rated scales such as Positive and Negative Syndrome Scale (PANSS). In this study, we aggregate multi-centre recordings to assemble a large corpus and assess symptom-prediction models at scale, to enable rater-independent, efficient, and reproducible assessments for early detection of relapse-related signals from speech. Methods: In this computational secondary analysis, we compiled data from 453 patients with schizophrenia spectrum disorders, recruited between 2005 and 2026 from ten global sites in the Czech Republic, United States, Spain, Chile, France, Switzerland, the Netherlands, Türkiye, Germany, and China, and clipped their speech recordings into 6,664 segments. Across three featuresets, acoustic-prosodic profile, pretrained multilingual embeddings, and their concatenation, we compared 16 algorithms in separate item-specific models to predict eight relapse-related PANSS items, including three positive (P1, P2, P3), three negative (N1, N4, N6), and two general (G5, G9) items, on speaker-disjoint splits. Performance was assessed by root-mean-squared-error (RMSE) at both segment and participant (median-aggregation) levels. Best model per item underwent bias checks for age, sex, education, and symptom severity. Findings: Best-performing models predicted symptoms with prediction errors of 1·5 or lower: P1 1·544/1·527, P2 1·318/1·107, P3 1·487/1·542, N1 1·071/1·030, N4 1·521/1·430, N6 0·869/0·855, G5 0·951/0·882, G9 1·298/1·282 (segment/participant). Performance of pretrained embeddings surpassed acoustic-prosodic features and concatenation. Results were comparable in languages or language variants with fewer available speech and language computational resources. We found no bias by age, sex, or education, aside from reduced N4 accuracy in males; but performance degraded with higher symptom severity. Interpretation: Speech can support automatic assessment of schizophrenia symptoms using pretrained embeddings, even without transcripts. Such models show promise as clinically meaningful, efficient, and low-burden tools for real-time monitoring of symptom trajectories. Future work should validate these models prospectively in higher-severity samples and improve clinical interpretability.

Indexed as

digital phenotypingmultilingual modellingPANSSSchizophreniaspeechsymptom prediction

Identifiers

PMID42856583
PMCPMC13648677

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.